TEVA 8-K 2026-10-29

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) 8-K dated 2026-10-29 — accession 0001193125-26-438019.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) common stock.

TEVA PHARMACEUTICAL INDUSTRIES LTD filed a 8-K on 2026-10-29. Accession 0001193125-26-438019.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported TEVA revenue for 2025-12-31 was $17.26B. Net income was $1.41B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31.

Not investment advice. The TEVA SEC hub lists recent forms. The stock page is the research view.